Home / E2F3 Knockout Cell Lines

E2F3 Knockout Cell Lines

Gene: E2F3

Official Full Name: E2F transcription factor 3provided by HGNC

Gene Summary: This gene encodes a member of a small family of transcription factors that function through binding of DP interaction partner proteins. The encoded protein recognizes a specific sequence motif in DNA and interacts directly with the retinoblastoma protein (pRB) to regulate the expression of genes involved in the cell cycle. Altered copy number and activity of this gene have been observed in a number of human cancers. There are pseudogenes for this gene on chromosomes 2 and 17. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2013]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO07137 E2F3 Knockout cell line (HeLa) Human E2F3 1:3~1:6 Negative Online Inquiry
KO07138 E2F3 Knockout cell line (HCT 116) Human E2F3 1:2~1:4 Negative Online Inquiry
KO07139 E2F3 Knockout cell line (HEK293) Human E2F3 1:3~1:6 Negative Online Inquiry
KO07140 E2F3 Knockout cell line (A549) Human E2F3 1:3~1:4 Negative Online Inquiry

Background

E2F3 Gene Knockout Cell Lines are specialized cell lines that have been genetically modified to disrupt the E2F3 gene, a critical transcription factor involved in the regulation of the cell cycle and DNA synthesis. By eliminating the function of E2F3, researchers can investigate its role in cell proliferation, apoptosis, and tumorigenesis, thereby providing insights into various malignancies and developmental disorders.

These cell lines function by utilizing advanced CRISPR/Cas9 gene editing technology, which allows for precise alterations to the genome. The knockout of E2F3 leads to alterations in gene expression profiles, facilitating the study of downstream targets and signaling pathways influenced by E2F3. Researchers can utilize these modifications to understand how E2F3 contributes to cancer biology, thus aiding in the identification of potential therapeutic targets.

The scientific importance of E2F3 Gene Knockout Cell Lines lies in their utility in both fundamental research and preclinical studies. They serve as a valuable tool for cancer research, especially in testing the efficacy of new drugs and understanding resistance mechanisms. Additionally, these cell lines can provide a platform for high-throughput screening of compounds that may restore normal cell cycle regulation.

Choosing E2F3 Gene Knockout Cell Lines over alternatives is advantageous due to their enhanced specificity and reliability in studying gene function related to tumorigenesis. Unlike conventional methods, CRISPR/Cas9 technology enables researchers to produce consistent knockout models with minimal off-target effects, thus ensuring data integrity.

Researchers and clinicians will find these cell lines invaluable as they forge new pathways in cancer research and therapeutic development. The ability to elucidate the role of E2F3 in various cellular processes enables the advancement of targeted therapies, ultimately contributing to improved patient outcomes.

Our company, a leader in the field of genetic engineering and cell line development, is committed to providing high-quality biological products that empower researchers with cutting-edge tools for discovery. Our expertise ensures that each E2F3 Gene Knockout Cell Line meets rigorous standards for accuracy and usability, making it a vital addition to any research laboratory.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.